Flare Therapeutics
Cambridge, United States· Est.
Flare Therapeutics discovers small molecule medicines targeting transcription factors in oncology and neurology.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $123M
About
Flare Therapeutics discovers small molecule medicines targeting transcription factors in oncology and neurology.
OncologyNeuroscienceSmall Molecules
Funding History
1Total raised:$123M
Series A$123M